OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
88
Results
Show all
Save search
Copy query
Show results for
Unknown
(88)
Publication Date
Release Date
2025
(12)
2021
(11)
2024
(10)
2022
(10)
2018
(8)
2020
(6)
2023
(5)
2014
(5)
2011
(5)
2019
(3)
2015
(3)
2026
(2)
2013
(2)
2012
(2)
2009
(2)
2016
(1)
2008
(1)
Previous
page
1 / 9
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
9
Next
page
Sort
by:
Relevance
Page size
10
Impact of Surveillance Imaging Modality on Survival After Recurrence in Patients With Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group.
Not available
S-EPMC6269130
|
biostudies-literature
Cite
Treatment of Stage IV Favorable Histology Wilms Tumor With Lung Metastases: A Report From the Children's Oncology Group AREN0533 Study.
Not available
S-EPMC6075846
|
biostudies-literature
Cite
Prodrugs for colon-restricted delivery: Design, synthesis, and in vivo evaluation of colony stimulating factor 1 receptor (CSF1R) inhibitors.
Not available
S-EPMC6128612
|
biostudies-literature
Cite
The classification of pediatric and young adult renal cell carcinomas registered on the children's oncology group (COG) protocol AREN03B2 after focused genetic testing.
Not available
S-EPMC6108909
|
biostudies-literature
Cite
Outcome analysis of stage I epithelial-predominant favorable-histology Wilms tumors: A report from Children's Oncology Group study AREN03B2.
Not available
S-EPMC7717680
|
biostudies-literature
Cite
Imaging Characteristics of Nephrogenic Rests Versus Small Wilms Tumors: A Report From the Children's Oncology Group Study AREN03B2.
Not available
S-EPMC7756929
|
biostudies-literature
Cite
Adaptive Manufacturing for Healthcare During the COVID-19 Emergency and Beyond.
Not available
S-EPMC8757720
|
biostudies-literature
Cite
A prospective study of pediatric and adolescent renal cell carcinoma: A report from the Children's Oncology Group AREN0321 study.
Not available
S-EPMC7717658
|
biostudies-literature
Cite
Impact of Pulmonary Tumor Burden in Favorable Histology Wilms Tumor Outcomes: A Report From the Children's Oncology Group Study AREN0533.
Not available
S-EPMC12646512
|
biostudies-literature
Cite
Augmentation of Therapy for Combined Loss of Heterozygosity 1p and 16q in Favorable Histology Wilms Tumor: A Children's Oncology Group AREN0532 and AREN0533 Study Report.
Not available
S-EPMC7001789
|
biostudies-literature
Cite
Previous
page
1 / 9
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
9
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets